Skip to the main content.

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Veranex Blog

2 min read

Medical Writing in Early Phase Studies

Is specialized knowledge needed for Medical Writers working on early phase studies? Based on the characteristics and needs of Phase 1, 1a, 1b, BA-BE studies, the answer would be yes. THE FOCUS OF EARLY-STAGE STUDIES Most early phase studies focus on...

Read More

2 min read

Three Key Points to Prepare for an Early Phase Clinical Trial

Companies preparing for an early phase study must deal with an array of challenges and decisions for biometrics, pharmacovigilance and regulatory...

Read More

3 min read

Plan to Mitigate Challenges in Pharmacovigilance and Drug Safety

Biopharmaceutical companies worldwide are developing better and most cost-effective medicines at an unprecedented rate. With billions of dollars...

Read More

2 min read

China Reveals Its 2025 Coverage Goals for Publicly Funded Healthcare

In September 2021, China’s National Healthcare Security Administration (NHSA), the government agent in charge of publicly funded healthcare announced...

Read More

2 min read

Provider and Patient Preference Studies: Demonstrating Product Demand for Drugs, Medical Devices, and Diagnostics

Pharmaceutical manufacturers, medical device companies, and advanced diagnostic manufacturers are increasingly incorporating patients’ and providers’...

Read More

1 min read

China Aims to Complete Transition to DRG Payment Model for Inpatient Care by 2024

In November 2021, the Chinese government announced its 3-year (2022-2024) payment reform plan with the end goal to fully implement a diagnosis...

Read More

2 min read

NCCN 2021 Conference Highlights: Elevating Racial Equity in Cancer Care

The National Comprehensive Cancer Network (NCCN) 2021 Annual Conference convened virtually March 18-20, drawing attendees from more than 40 countries...

Read More

4 min read

Is China a 300 Million or 1.4 Billion Healthcare Population Market?

A reflection on the 2019 capability development progress report of the county hospitals in China The Veranex (formerly Boston Healthcare Associates)...

Read More

1 min read

Veranex Partners with Alcon to Conduct Real-World Study Highlighting Efficiencies of Optical Biometer in Cataract Surgery

Alcon, a global leader in eye care, collaborated with Veranex (formerly Boston Healthcare Associates) to conduct a Time-and-Motion Study to support...

Read More